PCVX logo

Vaxcyte (PCVX) Cash from investing

annual CFI:

-$2.01B-$1.23B(-159.36%)
December 31, 2024

Summary

  • As of today (June 28, 2025), PCVX annual cash flow from investing activities is -$2.01 billion, with the most recent change of -$1.23 billion (-159.36%) on December 31, 2024.
  • During the last 3 years, PCVX annual CFI has fallen by -$1.79 billion (-844.70%).
  • PCVX annual CFI is now -2789.10% below its all-time high of $74.58 million, reached on December 31, 2022.

Performance

PCVX Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

quarterly CFI:

$123.32M+$680.49M(+122.13%)
March 31, 2025

Summary

  • As of today (June 28, 2025), PCVX quarterly cash flow from investing activities is $123.32 million, with the most recent change of +$680.49 million (+122.13%) on March 31, 2025.
  • Over the past year, PCVX quarterly CFI has increased by +$574.39 million (+127.34%).
  • PCVX quarterly CFI is now at all-time high.

Performance

PCVX quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

TTM CFI:

-$1.43B+$574.39M(+28.64%)
March 31, 2025

Summary

  • As of today (June 28, 2025), PCVX TTM cash flow from investing activities is -$1.43 billion, with the most recent change of +$574.39 million (+28.64%) on March 31, 2025.
  • Over the past year, PCVX TTM CFI has dropped by -$654.99 million (-84.38%).
  • PCVX TTM CFI is now -1393.88% below its all-time high of $110.62 million, reached on September 30, 2022.

Performance

PCVX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

PCVX Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-159.4%+127.3%-84.4%
3 y3 years-844.7%+148.3%-10000.0%
5 y5 years-10000.0%+10000.0%-10000.0%

PCVX Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-2789.1%at lowat high+113.5%-1393.9%+28.6%
5 y5-year-2789.1%at lowat high+113.5%-1393.9%+28.6%
alltimeall time-2789.1%at lowat high+113.5%-1393.9%+28.6%

PCVX Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
$123.32M(-122.1%)
-$1.43B(-28.6%)
Dec 2024
-$2.01B(+159.4%)
-$557.17M(-39.2%)
-$2.01B(+37.1%)
Sep 2024
-
-$917.02M(+1040.5%)
-$1.46B(+179.6%)
Jun 2024
-
-$80.41M(-82.2%)
-$523.13M(-32.6%)
Mar 2024
-
-$451.07M(+3139.1%)
-$776.28M(+0.4%)
Dec 2023
-$773.31M(-1136.8%)
-$13.93M(-162.5%)
-$773.31M(-2.8%)
Sep 2023
-
$22.28M(-106.7%)
-$795.34M(+1.6%)
Jun 2023
-
-$333.56M(-25.6%)
-$782.91M(+85.0%)
Mar 2023
-
-$448.10M(+1146.4%)
-$423.18M(-667.4%)
Dec 2022
$74.58M(-135.1%)
-$35.95M(-203.6%)
$74.58M(-32.6%)
Sep 2022
-
$34.71M(+32.6%)
$110.62M(+92.6%)
Jun 2022
-
$26.16M(-47.3%)
$57.44M(+434.4%)
Mar 2022
-
$49.67M(>+9900.0%)
$10.75M(-105.1%)
DateAnnualQuarterlyTTM
Dec 2021
-$212.31M(>+9900.0%)
$82.00K(-100.4%)
-$212.31M(-0.4%)
Sep 2021
-
-$18.47M(-10.0%)
-$213.11M(+9.5%)
Jun 2021
-
-$20.53M(-88.2%)
-$194.62M(+11.8%)
Mar 2021
-
-$173.39M(>+9900.0%)
-$174.15M(>+9900.0%)
Dec 2020
-$1.10M(-7.5%)
-$722.00K(-3538.1%)
-$1.10M(-17.3%)
Sep 2020
-
$21.00K(-138.2%)
-$1.34M(-5.7%)
Jun 2020
-
-$55.00K(-84.2%)
-$1.42M(-7.3%)
Mar 2020
-
-$349.00K(-63.4%)
-$1.53M(+27.9%)
Dec 2019
-$1.20M(-32.6%)
-$953.00K(+1488.3%)
-$1.20M(+393.8%)
Sep 2019
-
-$60.00K(-63.9%)
-$242.00K(+33.0%)
Jun 2019
-
-$166.00K(+937.5%)
-$182.00K(+1037.5%)
Mar 2019
-
-$16.00K
-$16.00K
Dec 2018
-$1.77M
-
-

FAQ

  • What is Vaxcyte annual cash flow from investing activities?
  • What is the all time high annual CFI for Vaxcyte?
  • What is Vaxcyte annual CFI year-on-year change?
  • What is Vaxcyte quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Vaxcyte?
  • What is Vaxcyte quarterly CFI year-on-year change?
  • What is Vaxcyte TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Vaxcyte?
  • What is Vaxcyte TTM CFI year-on-year change?

What is Vaxcyte annual cash flow from investing activities?

The current annual CFI of PCVX is -$2.01B

What is the all time high annual CFI for Vaxcyte?

Vaxcyte all-time high annual cash flow from investing activities is $74.58M

What is Vaxcyte annual CFI year-on-year change?

Over the past year, PCVX annual cash flow from investing activities has changed by -$1.23B (-159.36%)

What is Vaxcyte quarterly cash flow from investing activities?

The current quarterly CFI of PCVX is $123.32M

What is the all time high quarterly CFI for Vaxcyte?

Vaxcyte all-time high quarterly cash flow from investing activities is $123.32M

What is Vaxcyte quarterly CFI year-on-year change?

Over the past year, PCVX quarterly cash flow from investing activities has changed by +$574.39M (+127.34%)

What is Vaxcyte TTM cash flow from investing activities?

The current TTM CFI of PCVX is -$1.43B

What is the all time high TTM CFI for Vaxcyte?

Vaxcyte all-time high TTM cash flow from investing activities is $110.62M

What is Vaxcyte TTM CFI year-on-year change?

Over the past year, PCVX TTM cash flow from investing activities has changed by -$654.99M (-84.38%)
On this page